Sequential delivery of interferon-agene and DCs to intracranial gliomas promotes an effective antitumor response.
- Published in:
- Gene Therapy, 2004, v. 11, n. 21, p. 1551, doi. 10.1038/sj.gt.3302300
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2004 AND VI 11 AND IP 21
Results: 8
1
2
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
- Published in:
- Gene Therapy, 2004, v. 11, n. 21, p. 1559, doi. 10.1038/sj.gt.3302308
- By:
- Publication type:
- Article
3
Self-inactivating retroviral vectors with improved RNA processing.
- Published in:
- Gene Therapy, 2004, v. 11, n. 21, p. 1568, doi. 10.1038/sj.gt.3302309
- By:
- Publication type:
- Article
4
Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer.
- Published in:
- Gene Therapy, 2004, v. 11, n. 21, p. 1579, doi. 10.1038/sj.gt.3302319
- By:
- Publication type:
- Article
5
Robust functional gene validation by adenoviral vectors: one-step Escherichia coli-Derived Recombinant Adenoviral Genome construction.
- Published in:
- Gene Therapy, 2004, v. 11, n. 21, p. 1599, doi. 10.1038/sj.gt.3302333
- By:
- Publication type:
- Article
6
HER-2/neu immunotherapies: Take two-get more: optimization strategies for HER-2/neu-based immunotherapies inhibiting carcinogenesis.
- Published in:
- Gene Therapy, 2004, v. 11, n. 21, p. 1549, doi. 10.1038/sj.gt.3302340
- By:
- Publication type:
- Article
7
Messenger RNA electroporation is highly efficient in mouse embryonic stem cells: successful FLPe- and Cre-mediated recombination.
- Published in:
- Gene Therapy, 2004, v. 11, n. 21, p. 1606, doi. 10.1038/sj.gt.3302342
- By:
- Publication type:
- Article
8
Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model.
- Published in:
- Gene Therapy, 2004, v. 11, n. 21, p. 1590, doi. 10.1038/sj.gt.3302314
- By:
- Publication type:
- Article